v3 Template
E

Excelsior Sciences

Biotechnology and Chemistry ~640 employees
Founded
--
Employees (Est.)
~640
32 leaders known
Total Funding
$95.0M
Funding Rounds
1
Last Funding
2025-12-03

About Excelsior Sciences

Excelsior Sciences is focused on revolutionizing small-molecule innovation by leveraging chemistry that machines can perform. Using 'Blocc Chemistry,' they transform the synthesis process into a modular, iterative, and automation-friendly system, integrating AI and enabling seamless scaling from discovery to manufacturing. Their initial focus is on medicines, with a broader vision to reimagine various applications.

Products & Services

Blocc Chemistry:A new approach to iterative carbon-carbon bond formation that is compatible with automation, AI, and non-specialists, serving as the foundation for a new chemistry language model.
Closed-loop Learning:AI-guided automated iterative synthesis and testing to enhance the accuracy of foundation models predicting molecular properties like solubility and toxicity for pharmaceuticals.
Closed-loop Discovery:AI-driven use of foundation models and automated synthesis to discover small molecules with targeted functional properties, optimizing objective functions.

Specialties

Small Molecule Synthesis Automation in Chemistry AI-guided Chemical Discovery Pharmaceutical Development

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A
T: -
FT: Series A
A: 95000000
MR: -
FA: $95 million
FAN: 95000000
D: 2025-12-03
FD: 2025-12-03
6 investors
Series A Latest
2025-12-03
$95.0M
6 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

Michael Foley, Ph.D.

Co-Founder and Chief Executive Officer

LinkedIn (Pro only)
J

Jana Jensen

Co-founder and Chief Operating Officer

LinkedIn (Pro only)
J

John Ginn

Head of Medicinal Chemistry

LinkedIn (Pro only)
B

Brian Goldman

Vice President of AI and Data Sciences, Excelsior Sciences

M

Marc Feiglin

Chief Technology Officer

M

Martin Burke

Co-founder, Excelsior Sciences

View 29 more team members with Pro

Unlock Full Team Directory

Recent News

Excelsior Sciences Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology and Chemistry
Company Size
~640 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro